{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:16:39Z","timestamp":1790615799883,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpsychires.2026.06.007","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:21:56Z","timestamp":1780417316000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Priorities for psychedelic research among people who use psychedelics"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2757-7016","authenticated-orcid":false,"given":"Daniel J.","family":"Kruger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Czerew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Farquhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Redfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Colvard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutaz","family":"Faqqouseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moss","family":"Herberholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas G.","family":"Glynos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Boehnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.007_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/02791072.2019.1581961","volume":"51","author":"Aday","year":"2019","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib2","article-title":"Ethical considerations in conducting psychedelic research","author":"Appelbaum","year":"2022","journal-title":"NIH Workshop on Psychedelics as Therapeutics: Gaps, Challenges and Opportunities"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpsychires.2023.06.028","article-title":"Arketamine for bipolar depression: open-label, dose-escalation, pilot study","volume":"164","author":"Bandeira","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2026.06.007_bib4","series-title":"Elsevier Reference Collection Neuroscience and Biobehavioral Psychology","first-page":"1","article-title":"Psychedelic psychiatry","author":"Bender","year":"2024"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpsychires.2022.03.008","article-title":"MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD","volume":"149","author":"Brewerton","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"15","key":"10.1016\/j.jpsychires.2026.06.007_bib6","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/jama.2014.11100","article-title":"The PCORI perspective on patient-centered outcomes research","volume":"312","author":"Frank","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib7","series-title":"Psychedelic Drugs Reconsidered","author":"Grinspoon","year":"1979"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib8","article-title":"Set and settings in psychedelic clinical trials and moving forward","author":"Hartogsohn","year":"2022","journal-title":"NIH Workshop on Psychedelics as Therapeutics: Gaps, Challenges and Opportunities"},{"issue":"11","key":"10.1016\/j.jpsychires.2026.06.007_bib9","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2105\/AJPH.2009.170506","article-title":"Community-based participatory research: a capacity-building approach for policy advocacy aimed at eliminating health disparities","volume":"100","author":"Israel","year":"2010","journal-title":"Am J Public Health"},{"issue":"10","key":"10.1016\/j.jpsychires.2026.06.007_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1037\/h0032231","article-title":"Qualities for the community psychologist","volume":"26","author":"Kelly","year":"1971","journal-title":"Am. Psychol."},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.007_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/02791072.2023.2228784","article-title":"Preferences and support for psychedelic policies and practices among those using psychedelics","volume":"55","author":"Kruger","year":"2023","journal-title":"J Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.jpsychires.2026.06.007_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/02791072.2023.2201263","article-title":"\"How do I learn more about this?\": utilization and trust of psychedelic information sources among people naturalistically using psychedelics","volume":"55","author":"Kruger","year":"2023","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib13","series-title":"Resolving Social Conflicts, Selected Papers on Group Dynamic","first-page":"143","article-title":"Action research and minority problems","author":"Lewin","year":"1946"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jpsychires.2024.10.009","article-title":"The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression","volume":"180","author":"Marwood","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.06.007_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/medhum-2021-012299","article-title":"Psychedelic injustice: should bioethics tune in to the voices of psychedelic-using communities?","volume":"48","author":"Miceli McMillan","year":"2022","journal-title":"Med. Humanit."},{"key":"10.1016\/j.jpsychires.2026.06.007_bib16","article-title":"Considerations of study design and interaction of medication and medical practice in drug registration trials","author":"Muniz","year":"2022","journal-title":"NIH Workshop on Psychedelics as Therapeutics: Gaps, Challenges and Opportunities"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib17","article-title":"Overcoming confounds in psychedelic clinical trials: designs and measurement","author":"Muthukumaraswamy","year":"2022","journal-title":"NIH Workshop on Psychedelics as Therapeutics: Gaps, Challenges and Opportunities"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111155","article-title":"Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: a systematic review of evidence and efficacy","volume":"136","author":"Ordovich-Clarkson","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2026.06.007_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/brainsci15060572","article-title":"The potential role of psilocybin in traumatic brain injury recovery: a narrative review","volume":"15","author":"Palmer","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.jpsychires.2026.06.007_bib21","series-title":"As Investors Pile into Psychedelics, Idealism Gives Way to Pharma Economics","author":"Perrone","year":"2024"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib22","series-title":"Psychedelics Legalization & Decriminalization Tracker","year":"2024"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.06.007_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00919275","article-title":"Terms of empowerment\/exemplars of prevention: toward a theory for community psychology","volume":"15","author":"Rappaport","year":"1987","journal-title":"Am. J. Community Psychol."},{"key":"10.1016\/j.jpsychires.2026.06.007_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpsychires.2021.03.002","article-title":"Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review","volume":"137","author":"Romeo","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2026.06.007_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jpsychires.2023.03.031","article-title":"Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder","volume":"161","author":"Schneier","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.007_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2022.4101","article-title":"Psychedelic drug legislative reform and legalization in the US","volume":"80","author":"Siegel","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib27","series-title":"Storming Heaven: LSD and the American Dream","author":"Stevens","year":"1987"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib29","series-title":"NIH Psychedelics Workshop\u2014Where Are the Research Gaps and Opportunities? NIH Workshop on Psychedelics as Therapeutics: Gaps, Challenges and Opportunities","author":"Volkow","year":"2022"},{"key":"10.1016\/j.jpsychires.2026.06.007_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108071","article-title":"Trends in LSD use among US adults: 2015-2018","volume":"212","author":"Yockey","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.06.007_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1556\/2054.2020.00159","article-title":"Use of psilocybin (\u201cmushrooms\u201d) among US adults: 2015\u20132018","volume":"5","author":"Yockey","year":"2021","journal-title":"J Psychedelic Stud."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626003055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626003055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:29:14Z","timestamp":1790612954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626003055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"alternative-id":["S0022395626003055"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.06.007","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Priorities for psychedelic research among people who use psychedelics","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}